During the past decade, University of Pretoria Clinical Research Unit conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 6 clinical trials were completed, i.e. on average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Pretoria Clinical Research Unit" #1 sponsor was "Pfizer" with 3 trials, followed by "Bayer" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Biota Scientific Management Pty Ltd" with 1 trials sponsored and "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Pretoria Clinical Research Unit" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator, "Department of Health and Human Services" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Orion Corporation, Orion Pharma" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "University of Pretoria Clinical Research Unit" are "Rheumatoid Arthritis" (2 trials), "Arthritis" (1 trials), "Castration-Resistant Prostatic Cancer" (1 trials), "Influenza" (1 trials) and "Leiomyoma" (1 trials). Many other conditions were trialed in "University of Pretoria Clinical Research Unit" in a lesser frequency.

Most popular intervention types in "University of Pretoria Clinical Research Unit" are "Drug" (11 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "40 mg Laninamivir Octanoate" (1 trials), "80 mg Laninamivir Octanoate" (1 trials), "Abiraterone Acetate" (1 trials) and "Adalimumab with methotrexate" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Pretoria Clinical Research Unit" are 7 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University of Pretoria Clinical Research Unit". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in University of Pretoria Clinical Research Unit, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in University of Pretoria Clinical Research Unit, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".